This invention relates to a system for removing carbon dioxide (CO2) emissions from an inhalation therapy system, and specifically to a CO2 sorbent assembly for extracting metabolically produced CO2 from exhaled air.
Many diseases and medical conditions are currently being treated by inhalation therapy in which an aerosol medication is inhaled by a patient. Such treatments require inhalation of a proportionally large amount of aerosol medication relative to a low amount of medication that is actually absorbed into the patient's lungs. A relatively large amount of medication is wasted simply by being exhaled during a normal breathing cycle.
Currently systems for controlling and eliminating CO2 from a breathable air supply are utilized in diving applications, submarines, space vehicles and space suits. These systems utilize a CO2 sorbent bed composed of a solid or liquid sorbent disposed within a container. A stream of air containing CO2 is flowed through the container and the sorbent. The CO2 reacts with the sorbent, trapping CO2 within the container. The remainder of the breathable air recirculates into the controlled environment. Once the container has become saturated with CO2 such that further absorption of CO2 is inefficient, the breathable air stream is switched to a second container. The saturated container is either disposed or regenerated. Such systems have proven effective and efficient for controlling CO2 content within enclosed environments; however, these sorbent systems would tend to remove aerosolized particles within the air stream during inhalation therapy.
Accordingly, it is desirable to employ CO2 sorbent technology in an inhalation therapy system for controlling CO2 levels and increasing system efficiency by reusing exhaled aerosol medication.
A disclosed embodiment of this invention is an assembly for controlling the amount of carbon dioxide (CO2) within a recirculating inhalation therapy system with a CO2 sorbent while allowing reuse of medication in aerosol form by the inhalation therapy system.
The assembly of this invention removes CO2 from a recirculating inhalation therapy system with a CO2 sorbent. The CO2 sorbent assembly includes several CO2 sorbent layers disposed within a housing. The housing includes perforated sheets defining an inlet and an outlet. Between the CO2 sorbent sheets is an airflow passage. The airflow passage is unobstructed by CO2 sorbent, allowing the free flow of air through the assembly. Carbon dioxide is drawn from the airflow and absorbed in the CO2 sorbent. Because the airflow proceeds through the CO2 sorbent assembly uninterrupted, any aerosol medication remaining in the exhaled air of the patient will proceed directly through and substantially uninhibited by CO2 sorbent assembly for readministration to the patient. In this way, a substantial amount of otherwise wasted medication input into the system is administered to the patient.
Accordingly, the CO2 sorbent assembly of this invention controls carbon dioxide within a recirculating inhalation therapy system without trapping aerosol medication.
The various features and advantages of this invention will become apparent to those skilled in the art from the following detailed description of the currently preferred embodiment. The drawings that accompany the detailed description can be briefly described as follows:
Referring to
The CO2 sorbent sheets 16 combine to define airflow passage 22 through the assembly 12. Airflow through the sorbent assembly 12 is drawn into the CO2 sorbent by a pressure gradient created by the normal breathing cycle of a patient drawing air through the airflow passages 22. The exhaled air flow 24 is directed into the CO2 sorbent. The amount of CO2 absorbed by the assembly 12 depends on the flow rate of the exhaled air, the number of sorbent sheets 16 and the dimensions of the airflow passages 22. The higher the number of sorbent sheets 16, the greater the amount of CO2 absorbed. The larger the airflow passage 22, the less carbon dioxide absorbed by the CO2 sorbent assembly 12. A smaller airflow passage 22 results in a shorter diffusion path for the CO2 and a greater amount of CO2 is absorbed by sorbent layers 16. The number of sorbent sheets 16 and the specific dimensions of the airflow passage 22 are application specific and a worker knowledgeable in the art would understand how to vary these dimensions to produce the desired amount of CO2 absorption.
The CO2 sorbent sheets are wrapped in a Teflon wrap 18. The Teflon wrap 18 allows permeation of CO2 without allowing the release of CO2 sorbent into the inhalation therapy system 10. Further, the sorbent sheets 16 are separated from the airflow passage 22 by perforated sheets 34. The perforated sheets 34 provide structural support for the CO2 sorbent sheets 16 from the air flow passage 22.
Disposed within the sorbent sheets 16 are air passage fins 20. The air passage fins 20 define the airflow passage 22 through the assembly 12 (
Aerosol medication contained within the airflow 24 flows through the assembly 12 and is not absorbed or trapped within the CO2 sorbent layers 16. Airflow through the assembly 12 flows by the CO2 sorbent sheets 16 and therefore allows aerosol medication exhaled from a patient to pass through the assembly 12.
Referring to
The sorbent assembly 40 includes a diameter and a length 56, 58 and air passage fins 46. The diameter 56 and length 58 are sized according to certain applications specific requirements such as airflow rate and desired amount of CO2 absorption.
Referring to
The patient breathes in aerosol medication introduced into the system 10 by way of a nebulizer indicated at 72. As the patient inhales the medication, a certain amount of the aerosol medication remains within the patient and a certain amount is exhaled from the patient. Along with the exhaled excess aerosol medication, a certain amount of CO2 is exhaled as is normal during the breathing cycle. Air exhaled from the patient within the patient enclosure 70 is directed into a CO2 sorbent assembly 12,40 to remove a desired amount of CO2. The desired amount of CO2 is removed from the system while minimizing the amount of aerosol medication deposited within the sorbent assembly. Air drawn into the CO2 sorbent assembly 12, 40 is then output back into the patient enclosure 70. The inhalation therapy system illustrated in
Referring to
The CO2 sorbent assembly of this invention provides regulation and control of CO2 within an inhalation therapy system without substantially absorbing exhaled aerosol medication. Control of the CO2 within the inhalation therapy system allows for the re-breathing of exhaled aerosol medication that was not absorbed by the patient. The re-breathing of the aerosol medication provides a more efficient and cost effective inhalation therapy system 10.
The foregoing description is exemplary and not just a material specification. The invention has been described in an illustrative manner, and should be understood that the terminology used is intended to be in the nature of words of description rather than limitation. Many modifications and variations of the present invention are possible in light of the above teachings. The preferred embodiments of this invention have been disclosed, however, one of ordinary skill in the art would recognize that certain modifications are within the scope of this invention. It is understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described. For that reason the following claims should be studied to determine the true scope and content of this invention.
Number | Name | Date | Kind |
---|---|---|---|
2099954 | Cook | Nov 1937 | A |
3593712 | Weaver et al. | Jul 1971 | A |
3865924 | Gidaspow et al. | Feb 1975 | A |
4232667 | Chalon et al. | Nov 1980 | A |
4521038 | Cerny | Jun 1985 | A |
5072726 | Mazloomdoost et al. | Dec 1991 | A |
5079209 | Nalette et al. | Jan 1992 | A |
5091358 | Birbara et al. | Feb 1992 | A |
5174974 | Birbara et al. | Dec 1992 | A |
5281254 | Birbara et al. | Jan 1994 | A |
5376614 | Birbara et al. | Dec 1994 | A |
5427751 | Nalette et al. | Jun 1995 | A |
5454968 | Nalette et al. | Oct 1995 | A |
5492683 | Birbara et al. | Feb 1996 | A |
5595690 | Filburn et al. | Jan 1997 | A |
5620940 | Birbara et al. | Apr 1997 | A |
5681503 | Nalette et al. | Oct 1997 | A |
5829428 | Walters et al. | Nov 1998 | A |
5876488 | Birbara et al. | Mar 1999 | A |
5964221 | McKenna | Oct 1999 | A |
6041777 | Faithfull et al. | Mar 2000 | A |
6160193 | Gore | Dec 2000 | A |
6274785 | Gore | Aug 2001 | B1 |
6279576 | Lambert | Aug 2001 | B1 |
6364938 | Birbara et al. | Apr 2002 | B1 |
6439231 | Fukunaga et al. | Aug 2002 | B1 |
6675799 | Fuhrman et al. | Jan 2004 | B1 |
20030224504 | Blais et al. | Dec 2003 | A1 |
20040003808 | Fuhrman et al. | Jan 2004 | A1 |
Number | Date | Country |
---|---|---|
WO 9822173 | May 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20040079367 A1 | Apr 2004 | US |